Peptides & Research
Peptides & Research Compounds
We advise peptide merchants with legitimate script-certified prescribing workflows or documented research-use-only programs. Placement depends on prescriber credentials, pharmacy fulfilment, labelling and a compliance posture that separates the file from gray-market positioning.
Underwriting & acquiring considerations
We start from your existing environment — volumes, approval performance, disputes, reserves, banking and partner mix — then design the acquiring, redundancy and risk architecture around it, with scaling considerations built in.
Request an Assessment- Telehealth prescriber licensing and pharmacy fulfilment documentation
- Script-certified workflow versus research-use-only labelling
- COA, sourcing records and product-label compliance review
- Domestic versus offshore acquiring trade-offs
- Volume caps, minimums and reserve expectations
- Redundant MID planning ahead of category tightening
Engagement
Assess
Understand the merchant's current payment infrastructure, economics, risk profile, constraints and objectives.
Architect
Design an acquiring and payments strategy around resilience, performance, scalability and redundancy.
Select
Identify appropriate partners and manage the underwriting and implementation process.
Optimize
Continuously evaluate approval rates, costs, reserves, chargebacks, routing and overall payment performance.
Banking appetite and underwriting requirements vary by business model. We evaluate each company individually and never guarantee approval. Basis Point is not a bank, acquiring bank, payment processor or card network.